These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1319 related items for PubMed ID: 15023176

  • 21. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 22. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 24. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 25. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 07; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 26. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A.
    Indian J Med Res; 2006 Jan 07; 123(1):37-42. PubMed ID: 16567866
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D, Chevaliez S, Pawlotsky JM.
    Gastroenterology; 2008 Oct 07; 135(4):1185-91. PubMed ID: 18694749
    [Abstract] [Full Text] [Related]

  • 28. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
    Bal SH, Heper Y, Kumaş LT, Mistik R, Töre O.
    Mikrobiyol Bul; 2009 Apr 07; 43(2):243-50. PubMed ID: 19621609
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L, Holland P.
    Vox Sang; 2006 Jul 07; 91(1):1-12. PubMed ID: 16756595
    [Abstract] [Full Text] [Related]

  • 30. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J, Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
    Transfusion; 2008 Nov 07; 48(11):2308-14. PubMed ID: 18673347
    [Abstract] [Full Text] [Related]

  • 31. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor.
    Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K.
    Transfus Med; 2004 Apr 07; 14(2):97-103. PubMed ID: 15113374
    [Abstract] [Full Text] [Related]

  • 32. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb 07; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 33. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
    El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A.
    Transfus Med; 2008 Feb 07; 18(1):55-61. PubMed ID: 18279193
    [Abstract] [Full Text] [Related]

  • 34. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.
    Transfusion; 2007 Oct 07; 47(10):1794-802. PubMed ID: 17880603
    [Abstract] [Full Text] [Related]

  • 35. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct 07; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 36. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr 07; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 37. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
    Panhotra BR, Al-Bahrani A, Ul-Hassan Z.
    Saudi Med J; 2005 Feb 07; 26(2):270-3. PubMed ID: 15770304
    [Abstract] [Full Text] [Related]

  • 38. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M, Nübling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK.
    Vox Sang; 2006 Oct 07; 91(3):237-43. PubMed ID: 16958836
    [Abstract] [Full Text] [Related]

  • 39. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 07; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]

  • 40. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct 07; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 66.